A Global Perspective on Gastrointestinal Diseases

Gastroenterology Clinics of North America

Volumn 40, Issue 2, 2011, Pages 427-439

  Menon, Radha ^a   Riera, Andres ^a   Ahmad, Asyia ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Gender; Global; International

Indexed keywords

CURCUMIN; HEPATITIS B VACCINE; PLACEBO;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CROHN DISEASE; CULTURAL FACTOR; DIET; ENTERITIS; FECES INCONTINENCE; GASTROINTESTINAL DISEASE; GEOGRAPHY; HELICOBACTER INFECTION; HEPATITIS B; HUMAN; INCIDENCE; INDUSTRIALIZATION; IRRITABLE COLON; LIVER CELL CARCINOMA; PERSONAL HYGIENE; PREVALENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE; ULCERATIVE COLITIS; VACCINATION;

GASTROINTESTINAL DISEASES; HUMANS; PREVALENCE; WORLD HEALTH;

EID: 79956094134     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2011.03.002     Document Type: Review

References (61)

1. Logan I., Bowlus C. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 2010, 9:A372-A378.
2. Yamamoto T., Nakahigashi M., Saniabadi A.R. Review article: diet and inflammatory bowel disease-epidemiology and treatment. Aliment Pharmacol Ther 2009, 30:99-112.
3. Zvidi I., Hazazi R., Birkenfeld S., et al. The prevalence of Crohn's disease in Israel: a 20-year survey. Dig Dis Sci 2009, 54:848-852.
4. Birkenfeld S., Zvidi I., Hazazi I., et al. The prevalence of ulcerative colitis in Israel: a twenty-year survey. J Clin Gastroenterol 2009, 43(8):743-746.
5. Herrinton L.J., Liu L., Lewis J., et al. Incidence and prevalence of inflammatory bowel disease in a northern California managed care organization 1996-2002. Am J Gastroenterol 2008, 103:1998-2006.
6. Shivnanda S., Lennard-Jones J., Logan R., et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease. Gut 1996, 39(5):690-697.
7. Ladas S.D., Mala E., Giorgiotis K., et al. Incidence of ulcerative colitis in Central Greece: a prospective study. World J Gastroenterol 2005, 11:1785-1787.
8. Sincic B.M., Vucelic B., Persic M., et al. Incidence of inflammatory bowel disease in Primorsko-Goranska County, Croatia, 2000-2004: a prospective population-based study. Scand J Gastroenterol 2006, 41(4):437-444.
9. Sood A., Midha V., Sood N., et al. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003, 53(11):1587-1590.
10. Yang S.K., Yun S., Kim J.H., et al. Epidemiology of inflammatory bowel disease in Songpa-Kangdong district, Seoul, Korea. Inflamm Bowel Dis 2008, 14(4):542-549.
11. Bernstein C.N., Fried M., Krabshuis J.H., et al. Inflammatory bowel disease: a global perspective 2009, Global Guidelines, World Gastroenterology Organization, Available at:, Accessed March 21, 2011. http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/21_inflammatory_bowel_disease.pdf.
12. Pinsk F., Lemberg D., Grewal K., et al. Inflammatory bowel disease in South Asian pediatric population of British Columbia. Am J Gastroenterol 2007, 102:1077-1083.
13. Maizels R.M., Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 2003, 3:733-744.
14. Guarner F., Bourdet-Sicard R., Brandtzaeg P., et al. Mechanisms of disease: the hygiene hypothesis is revisited. Nat Clin Pract Gastroenterol Hepatol 2006, 3(5):275-284.
15. Summers R., Elliott D., Khurram Q., et al. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol 2003, 98(9):2034-2041.
16. Chuah S.Y., Jayanthi V., Lee C.N., et al. Dietary fats and inflammatory bowel disease in Asians. Ital J Gastroenterol 1992, 24:336-388.
17. Probert C., Bhakta P., Bhamra B., et al. Diet of South Asians with inflammatory bowel disease. Arq Gastroenterol 1996, 33(3):132-135.
18. Plummer S.M., Holloway K.A., Manson M.M., et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-KB activation via the NIK/IKK signaling complex. Oncogene 1999, 18:6013-6020.
19. Holt P.R., Katz S., Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci 2005, 50(11):2191-2193.
20. Hanai H., Iida T., Takeuchi K., et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006, 4:1502-1506.
21. Grundmann O., Yoon S.L. Irritable bowel syndrome: epidemiology, diagnosis, and treatment: an update for health-care practitioners. J Gastroenterol Hepatol 2010, 25:691-699.
22. Hahn B.A., Saunders W.B., Maier W.C. Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms. Dig Dis Sci 1997, 42(12):2585-2590.
23. Saito Y.A., Locke R., Talley N., et al. A comparison of the Rome and Manning Criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000, 95(10):2816-2824.
24. Quigley E., Fried M., Gwee K.A., et al. Irritable bowel syndrome: a global perspective 2009, Global Guideline, World Gastroenterology Organization, Available at:, Accessed March 21, 2011. http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/20_irritable_bowel_syndrome.pdf.
25. Gwee K.A., Lu C.L., Ghoshal U.C. Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol 2009, 24:1601-1607.
26. Miwa H. Prevalence of irritable bowel syndrome in Japan: internet survey using Rome III criteria. Patient Prefer Adherence 2008, 2:143-147.
27. Kumano H., Kaiya H., Yoshiuchi K., et al. Comorbidity of irritable bowel syndrome, panic disorder, and agoraphobia in Japanese representative sample. Am J Gastroenterol 2004, 99:70-76.
28. Ghoshal U.C., Abraham P., Bhatt C., et al. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol 2008, 27:22-28.
29. Husain N., Chaudhry I.B., Jafri F., et al. A population-based study of irritable bowel syndrome in a non-Western population. Neurogastroenterol Motil 2008, 20(9):1022-1029.
30. Shah S.S., Bhatia S.J., Mistry F.P. Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol 2001, 20(3):103-106.
31. Kwan A.C.P., Hu W.H., Chan Y.K., et al. Prevalence of irritable bowel syndrome in Hong Kong. J Gastroenterol Hepatol 2002, 17(11):1180-1186.
32. Gwee K.A. Irritable bowel syndrome in developing countries-a disorder of civilization of colonization?. Neurogastroenterol Motil 2005, 17:317-324.
33. Gwee K.A., Wee S., Wong M.L., et al. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol 2004, 99(5):924-931.
34. Linz B., Balloux F., Moodley Y., et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 2007, 445:915.
35. Naja F., Kreiger N., Sullivan T. Helicobacter pylori infection in Ontario: prevalence and risk factors. Can J Gastroenterol 2007, 21(8):501-506.
36. Smith J.G., Li W., Rosson R.S. Prevalence, clinical and endoscopic predictors of Helicobacter pylori infection in an urban population. Conn Med 2009, 73(3):133-137.
37. Graham D.Y., Malaty H.M., Evans D.G., et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991, 100(6):1495-1501.
38. Ahmed K.S., Khan A.A., Ahmed I., et al. Impact of household hygiene and water source on the prevalence and transmission of Helicobacter pylori: a South Indian perspective. Singapore Med J 2007, 48(6):543-549.
39. Nurgalieva Z.Z., Malaty H.M., Graham D.Y., et al. Helicobacter pylori infection in Kazakhstan: effect of water source and household hygiene. Am J Trop Med Hyg 2002, 67(2):201-206.
40. Fujimoto Y., Furusyo N., Toyoda K., et al. Intrafamilial transmission of Helicobacter pylori among the population of endemic areas of Japan. Helicobacter 2007, 12:170-176.
41. Malaty H.M. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 2007, 21(2):205-214.
42. Yim J.Y., Kim N., Choi S.H., et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007, 12(4):333-340.
43. Chen J., Bu X.L., Wang Q.Y., et al. Decreasing seroprevalence of Helicobacter pylori infection during 1993-2003 in Guangzhou, Southern China. Helicobacter 2007, 12(2):164-169.
44. Bures J., Kapacova M., Rejchrt S. Cas Lek Cesk 2008, 147(5):255-257. [in Czech].
45. Wu H.C., Tuo B.G., Wu W.M., et al. Prevalence of peptic ulcer in dyspeptic patients and the influence of age, sex, and Helicobacter pylori infection. Dig Dis Sci 2008, 53:2650-2656.
46. Manuel D., Cutler A., Goldstein J., et al. Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications. Aliment Pharmacol Ther 2007, 25(12):1423-1427.
47. Drossman D.A., Li Z., Andruzzi E., et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993, 38(9):1569-1580.
48. Nelson R., Norton N., Cautley E., et al. Community-based prevalence of anal incontinence. JAMA 1995, 274(7):559-561.
49. Hawes S.K., Ahmad A. Fecal incontinence: a woman's view. Am J Gastroenterol 2006, 101:S610-S617.
50. Whitehead W.E., Borrud L., Goode P.S., et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology 2009, 137:512-517.
51. Pretlove S.J., Radley S., Toozs-Hobson P.M., et al. Prevalence of anal incontinence according to age and gender: a systematic review and meta-regression analysis. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17:401-417.
52. Rizk D.E., El-Safty M.M. Female pelvic floor dysfunction in the Middle East: a tale of three factors-culture, religion and socialization of health role stereotypes. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17:436-438.
53. Rizk D.E., Hassan M.Y., Shaheen H., et al. The prevalence and determinants of health care-seeking behavior for fecal incontinence in multiparous United Arab Emirates females. Dis Colon Rectum 2001, 44(12):1850-1856.
54. Heathcote J, Abbas Z, Alberti A, et al. Hepatitis B. Global Guidelines. World Gastroenterology Organization; 2008. Available at: Accessed March 21, 2011. http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/12_hepatitis_b_en.pdf.
55. Centers for Disease Control and Prevention (CDC) Progress in hepatitis B prevention through universal infant vaccination-China, 1997-2006. MMWR Morb Mortal Wkly Rep 2007, 56(18):441-445.
56. Viral hepatitis: global policy: World Hepatitis Alliance; 2010.
57. Ferenci P., Fried M., Labrecque D., et al. Hepatocellular Carcinoma (HCC): a global perspective. Global Guidelines 2009, World Gastroenterology Organization, Available at:, Accessed March 21, 2011. http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/24_hepatocellular_carcinoma_en.pdf.
58. Groopman J.D., Scholl P., Wang J.S. Epidemiology of human aflatoxin exposures and their relationship to liver cancer. Prog Clin Biol Res 1996, 395:211-222.
59. Bulatao-Jayme J., Almero E.M., Castro M.C., et al. A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Int J Epidemiol 1982, 11(2):112-119.
60. Peers F., Bosch X., Kaldor J., et al. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int J Cancer 1987, 39(5):545-553.
61. Yeh F.S., Yu Mc, Mo C.C., et al. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 1989, 49(9):2506-2509.